A study conducted by the Australian CSIRO and published in Virology Journal demonstrated “[…]SARS-CoV-2 can remain infectious for significantly longer time periods than generally considered possible.”
Researchers at the KU Leuven Rega Institute gave SARS-CoV-2 infected hamsters either hydroxychloroquine (an anti-malarial drug) or favipiravir – a broad-spectrum antiviral drug used in in some countries to treat influenza.
A study published BMJ Open found that “[…} cloth masks must be washed daily to reduce the likelihood of contamination and transmission of viruses like SARS-CoV-2.”
A study published in Neurologic Sciences, looking at the impact of anosmia (loss of smell) on CoVID-19 prognosis, found “the presence of anosmia was an independent predictor of good outcome as reflected by a lower in-hospital mortality rate and less frequent ICU admission.